7.39 USD
↗ 0.31 (4.38%)AT CLOSE (11:59 AM EDT)
Verastem, Inc.
VSTMNASDAQ • USD
7.29
↘ 0.10 (1.30%)
POST MARKET (AS OF 07:51 PM EDT)
Post Market
AS OF 07:51 PM EDT
7.29
↘ 0.10 (1.30%)
Market: CLOSED
Verastem, Inc. (VSTM) trades at $7.39 per share. The technical outlook is "Buy" and the fundamental picture shows "Neutral". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Aug 26, 2026.
Open?$7.08
High?$7.45
Low?$6.91
Prev. Close?$7.08
Volume?1.7M
Avg. Volume?2.0M
VWAP?$7.23
Rel. Volume?0.83x
Bid / Ask
Bid?$7.20 × 2.5K
Ask?$7.39 × 5.0K
Spread?$0.19
Midpoint?$7.30
Valuation & Ratios
Market Cap?669.3M
Shares Out?90.6M
Float?84.4M
Float %?93.2%
P/E Ratio?N/A
P/B Ratio?13.39
EPS?-$2.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Employees
102
Market Cap
641.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2012-01-27
Address
117 KENDRICK STREET
NEEDHAM, MA 02494
Phone: (781) 292-4200
NEEDHAM, MA 02494
Phone: (781) 292-4200
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?0
Momentum?83
Short Sent.?45
Piotroski F-Score?4/9Mixed
Altman Z-Score?-7.48Distress
Confidence?51%Low
Short InterestSqueeze Risk
Short % of Float?22.40%Squeeze Risk
Short Interest?18.9M
Days to Cover?9.6
Free Float84.4M
Avg Daily Volume2.0M
Settlement Date2026-08-14
Financial Health
Current Ratio?2.25Strong
Quick Ratio?2.22Strong
Cash Ratio?1.75Strong
Debt/Equity?1.63High
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?13.39HIGH▾
Peers100
S&P14
P/S?7.65HIGH▾
Peers100
S&P14
P/FCF?N/A▾
EV/EBITDA?-3.9CHEAP▾
S&P97
EV/Sales?7.02HIGH▾
Peers100
S&P20
Returns & Efficiency
ROE?-405.5%WEAK▾
S&P3
ROA?-98.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-162195000
Enterprise Value?$614.6M
Fundamentals ratios updated end of day